当前位置: X-MOL 学术Infect. Drug Resist. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
The Impact of COVID-19 on Cancer
Infection and Drug Resistance ( IF 3.9 ) Pub Date : 2021-09-17 , DOI: 10.2147/idr.s324569
Yue Li 1 , Xingjian Wang 1 , Wei Wang 1
Affiliation  

Abstract: Since late December 2019, the 2019 coronavirus disease (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its rapid international spread have posed a global health threat. The World Health Organization has declared the outbreak of COVID-19 as “public health emergency of international concern”. COVID-19 not only brings tremendous pressure to the medical system but also brings new challenges to the global economy. The occurrence and development of cancer has always been an area of active research, and COVID-19 also has a long-lasting impact on the diagnosis, treatment, and research of cancer. In the context, we review the adverse effects of COVID-19 on the screening, diagnosis, treatment and prognosis of cancer patients and the countermeasures in this situation, and provide solutions for improving the quality of life of cancer patients in the normalized prevention and control of COVID-19.

Keywords: COVID-19, SARS-CoV-2, cancer


中文翻译:

COVID-19 对癌症的影响

摘要:自 2019 年 12 月下旬以来,由严重急性呼吸系统综合症冠状病毒 2 (SARS-CoV-2) 引起的 2019 冠状病毒病 (COVID-19) 及其迅速的国际传播已对全球健康构成威胁。世界卫生组织已宣布 COVID-19 的爆发为“国际关注的突发公共卫生事件”。COVID-19不仅给医疗系统带来巨大压力,也给全球经济带来新挑战。癌症的发生和发展一直是一个活跃的研究领域,而 COVID-19 也对癌症的诊断、治疗和研究产生了长期的影响。在此背景下,我们回顾了 COVID-19 对癌症患者筛查、诊断、治疗和预后的不利影响以及在这种情况下的对策,

关键词: COVID-19,SARS-CoV-2,癌症
更新日期:2021-09-16
down
wechat
bug